← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #928 OF 1,000 MOST-CITED

Investigator device accountability inadequate

FDA cited this observation 15 times across 15 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices15
BY FISCAL YEAR
FY20263
FY20242
FY20231
FY20221
FY20212
FY20202
FY20183
FY20171

How FDA worded it — real examples

Records of use of a device that relate to the dates of receipt and batch number or code mark of the device are not all accurate and complete.

Benjamin D. Elder, MD, PhD · Rochester, Minnesota · Devices · 2026-03-27

Records of use and disposal of a device that relate to the batch number or code mark of the device are not all accurate and complete.

Nicolas J. Mouawad, MD · Bay City, Michigan · Devices · 2026-03-20

Records of receipt, use and disposal of a device that relate to the type and quantity, dates of receipt and batch number or code mark of the device are not all accurate, complete and current.

Helena C. Chang, MD · Santa Clara, California · Devices · 2026-02-20

Records of receipt, use and disposal of a device that relate to the type and quantity, dates of receipt and batch number or code mark of the device are not all complete.

Randy D. Hicks, M.D. · Flint, Michigan · Devices · 2024-09-12

Records of receipt, use and disposal of a device that relate to the type and quantity, dates of receipt and batch number or code mark of the device are not all accurate.

Mara Piltin, D.O. · Rochester, Minnesota · Devices · 2024-05-03

Records of receipt, use and disposal of a device that relate to the batch number or code mark of the device are not all accurate and complete.

Howard M. Richard, III M.D. · Baltimore, Maryland · Devices · 2023-03-06

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Medical device qualityMedical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →